Metabolism of flavonoids via enteric recycling: Role of intestinal disposition

Journal of Pharmacology and Experimental Therapeutics

Volumn 304, Issue 3, 2003, Pages 1228-1235

  Chen, Jun ^a   Lin, Huimin ^a   Hu, Ming ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APIGENIN; FLAVONOID; GENISTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIOAVAILABILITY; CELL STRAIN CACO 2; CONTROLLED STUDY; DRUG METABOLISM; DRUG STRUCTURE; ENTEROHEPATIC CIRCULATION; FIRST PASS EFFECT; GLUCURONIDATION; INTESTINE ABSORPTION; LIVER MICROSOME; MALE; MICROSOME; NONHUMAN; PRIORITY JOURNAL; RAT; RECYCLING;

ANIMALS; APIGENIN; CACO-2 CELLS; FLAVONOIDS; GENISTEIN; HUMANS; INTESTINAL ABSORPTION; INTESTINES; LIVER; MALE; MICROSOMES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0037371414     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.102.046409     Document Type: Article

References (32)

1. Andlauer W, Kolb J, and Furst P (2000) Isoflavones from tofu are absorbed and metabolized in the isolated rat small intestine. J Nutr 130:3021-3027.
2. Birt DF, Hendrich S, and Wang W (2001) Dietary agents in cancer prevention: flavonoids and isoflavonoids. Pharmacol Ther 90:157-177.
3. Busby MG, Jeffcoat AR, Bloedon LT, Koch MA, Black T, Dix KJ, Heizer WD, Thomas BF, Hill JM, Crowell JA, et al. (2002) Clinical characteristics and pharmacokinetics of purified soy isoflavones: single-dose administration to healthy men. Am J Clin Nutr 75:126-136.
4. Cheng Z, Radominska-Pandya A, and Tephly TR (1999) Studies on the substrate specificity of human intestinal UDP-glucuronosyltransferases 1A8 and 1A10. Drug Metab Dispos 27:1165-1170.
5. Crespy V, Morand C, Manach C, Besson C, Demigne C, and Remesy C (1999) Part of quercetin absorbed in the small intestine is conjugated and further secreted in the intestinal lumen. Am J Physiol 277:G120-G126.
6. Doerge DR, Chang HC, Churchwell MI, and Holder CL (2000) Analysis of soy isoflavone conjugation in vitro and in human blood using liquid chromatographymass spectrometry. Drug Metab Dispos 28:298-307.
7. Galijatovic A, Otake Y, Walle UK, and Walle T (1999) Extensive metabolism of the flavonoid chrysin by human Caco-2 and Hep G2 cells. Xenobiotica 29:1241-1256.
8. Green MD, King CD, Mojarrabi B, Mackenzie PI, and Tephly TR (1998) Glucuronidation of amines and other xenobiotics catalyzed by expressed human UDP-glucuronosyltransferase 1A3. Drug Metab Dispos 26:507-512.
9. Gupta S, Afaq F, and Mukhtar H (2001) Selective growth-inhibitory, cell-cycle deregulatory and apoptotic response of apigenin in normal versus human prostate carcinoma cells. Biochem Biophys Res Commun 287:914-920.
10. Harborne JB and Williams CA (2000) Adv in flavonoid research since 1992. Phytochemistry 55:481-504.
11. Hong SJ, Kim SI, Kwon SM, Lee JR, and Chung BC (2002) Comparative study of concentration of isoflavones and lignans in plasma and prostatic tissues of normal control and benign prostatic hyperplasia. Yonsei Med J 43:236-241.
12. Hu M, Chen J, Tran D, Zhu Y, and Leonardo G (1994a) The Caco-2 cell monolayers as an intestinal metabolism model: metabolism of dipeptide Phe-Pro. J Drug Target 2:79-89.
13. Hu M, Chen J, Zhu Y, Dantzig AH, Stratford RE Jr, and Kuhfeld MT (1994b) Mechanism and kinetics of transcellular transport of a new β-lactam antibiotic loracarbef across an human intestinal epithelial model system (Caco-2). Pharm Res (NY) 11:1405-1413.
14. Hu M, Roland K, Ge L, Chen J, Tyle P, and Roy S (1998) Determination of absorption characteristics ofAG337, a novel thymidylate synthase inhibitor, using a perfused rat intestinal model. J Pharm Sci 87:886-890.
15. Hu M, Sinko PJ, DeMeere ALJ, Johnson DA, and Amidon GL (1988) Membrane permeability parameters for some amino acids and β-lactam antibiotics: application of the boundary layer approach. J Theor Biol 131:107-114.
16. Kelloff GJ, Lieberman R, Steele VE, Boone CW, Lubet RA, Kopelovich L, Malone WA, Crowell JA, Higley HR, and Sigman CC (2001) Agents, biomarkers and cohorts for chemopreventive agent development in prostate cancer. Urology 57 (Suppl 1):46-51.
17. King RA, Broadbent JL, and Head RJ (1996) Absorption and excretion of the soy isoflavone genistein in rats. J Nutr 126:176-182.
18. King RA and Bursill DB (1998) Plasma and urinary kinetics of the isoflavones daidzein andgenistein after a single soy meal in humans. Am J Clin Nutr 67:867-872.
19. Kurzer M and Xu X (1997) Dietary phytoestrogens. Annu Rev Nutr 17:353-381.
20. Li B, Pinch H, and Birt DF (1996) Influence of vehicle, distant topical delivery and biotransformation on the chemopreventive activity of apigenin, a plant flavonoid, in mouse skin. Pharm Res (NY) 13:1530-1534.
21. Liu Y and Hu M (2002) Absorption and metabolism of flavonoids in the Caco-2 cell culture model and a perfused rat intestinal model. Drug Metab Dispos 30:370-377.
22. Morton MS, Matos-Ferreira A, Abranches-Monteiro L, Correia R, Blacklock N, Chan PS, Cheng C, Lloyd S, Chieh-Ping W, and Griffiths K (1997) Measurement and metabolism of isoflavonoids and lignans in the human male. Cancer Lett 114:145-151.
23. Okita RT, Castle P, and Okita JR (1993) Characterization of cytochrome P450 in liver and kidney of rats treated with di-(2-ethylhexy)phthalate (DEHP). J Biochem Toxicol 8:135-144.
24. Roberts MS, Magnusson BM, Burczynski FJ, and Weiss M (2002) Enterohepatic circulation: physiological, pharmacokinetic and clinical implications. Clin Pharmacokinet 41:751-790.
25. Schneider H, Simmering R, Hartmann L, Pforte H, and Blaut M (2000) Degradation of quercetin-3-glucoside in gnotobiotic rats associated with human intestinal bacteria. J Appl Microbiol 89:1027-1037.
26. Setchell KD, Brown NM, Desai P, Zimmer-Nechemias L, Wolfe BE, Brashear WT, Kirschner AS, Cassidy A, and Heubi JE (2001) Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements. J Nutr 131:1362S-1375S.
27. Steele VE, Pereira MA, Sigman CC, and Kelloff GJ (1995) Cancer chemoprevention agent development strategies for genistein. J Nutr 125:713S-716S.
28. Wang W, Heideman L, Chung CS, Pelling JC, Koehler KJ, and Birt DF (2000) Cell-cycle arrest at G2/M and growth inhibition by apigenin in human colon carcinoma cell lines. Mol Carcinog 28:102-110.
29. Xu X, Harris K, Wang HJ, Murphy PA, and Hendrich S (1995) Bioavailability of soybean isoflavone depends upon gut microflora in women. J Nutr 125:2307-2315.
30. Xu X, Wang HJ, Murphy PA, Cook L, and Hendrich S (1994) Daidzein is a more bioavailable soymilk isoflavone than is genistein in adult women. J Nutr 124:825-832.
31. Walle UK and Walle T (2002) Induction of human UDP-glucuronosyltransferase UGT1A1 by flavonoids-structural requirements. Drug Metab Dispos 30:564-569.
32. Yang CS, Landau JM, Huang MT, and Newmark HL (2001) Inhibition of carcinogenesis by dietary polyphenolic compounds. Annu Rev Nutr 21:381-406.